Full access to all news articles, including in-depth analysis and opinion pieces.
Exclusive interviews with experts and influential figures.
Enhanced multimedia experience with videos, photo galleries, and interactive graphics.
Ad-free browsing for a seamless reading experience.
Global Insights
$
$
9.99
$
0
/ 30 days
/ 30 days
placeholder text
Global Insights Subscription:
All features of the Premium Subscription.
Exclusive access to monthly webinars or live Q&A sessions with our journalists and correspondents, providing insights into the news-gathering process and global events.
Customizable news alerts tailored to your specific interests and regions.
Early access to special investigative reports and in-depth features.
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023.Brendan McDermid | ReutersMedicare drug plans can now cover Eli...
Andrew Witty, CEO of UnitedHealth Group, testifies during the Senate Finance Committee hearing titled "Hacking America's Health Care: Assessing the Change Healthcare Cyber Attack and What's Next," in the...
Is it possible to be too merry and bright heading into the holiday season? The question is timely, given the unmistakable upwelling of investor enthusiasm toward equities in recent...
A Quarter Pounder with cheese, fries and a drink arranged at a McDonald's restaurant in El Sobrante, California, on Oct. 23, 2024.David Paul Morris | Bloomberg | Getty ImagesIn...
Once worth $6 billion, 23andMe has lost 98% of its value and is on the verge of being delisted from the Nasdaq after all of its independent board members...
Illegal migrant border encounters have plummeted since President Donald Trump took office in January and continue to trend at record lows compared to...